Insulin Prices | search
Click here to view Insulin Prices news from 60+ newspapers.
Bookmark or Share- Insulin Cost and Pricing Trends - AAFThis report analyzes the rising costs of insulin in the U.S., which account for 20 percent of the direct costs of treating diabetes. It projects that insulin spending could reach $121.2 billion by 2024, depending on the price growth trends of new and existing products.
- Research: Understanding the Insulin Market - AAFLearn about the insulin market in the U.S., including the main manufacturers, products, administration methods, and challenges. The web page does not mention the largest producer of insulin, but it provides some statistics and trends on insulin use and prices.
- Potential Cost Implications of Expected New “Generic” InsulinsThe article analyzes the impact of new insulin products, including biosimilars and authorized generics, on patient and taxpayer costs. It discusses the market dynamics, pricing and rebate structure, and regulatory pathways for insulin competition.
- The Build Back Better Act and the Challenge of Insulin PricesThe BBBA would require all insulin products to have their price set by the Secretary of Health and Human Services (HHS)—as part of a larger proposal to have Medicare “negotiate” drug prices—and would unilaterally limit cost-sharing for insulin through Part D to $35 per month. The BBBA’s insulin provisions would also reach into the ...
- Insulin Prices: An Update - AAFThe paper analyzes the impact of new, half-priced insulin products on average prices and spending in Medicaid and Medicare Part D from 2018 to 2020. It finds that prices have declined slightly, but few patients have switched to the lower cost products due to rebates, formulary placement, and patient preferences.
More
